BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 826944)

  • 1. Effect of some cannabinoids on naloxone-precipitated abstinence in morphine-dependent mice.
    Bhargava HN
    Psychopharmacology (Berl); 1976 Sep; 49(3):267-70. PubMed ID: 826944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome.
    Bhargava HN
    Pharmacol Biochem Behav; 1978 Jan; 8(1):7-11. PubMed ID: 564515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of naloxone-induced withdrawal in morphine dependent mice by 1-trans-delta9-tetrahydrocannabinol.
    Bhargava HN
    Eur J Pharmacol; 1976 Mar; 36(1):259-62. PubMed ID: 944134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphine-dependent rats: blockade of precipitated abstinence by tetrahydrocannabinol.
    Hine B; Friedman E; Torrelio M; Gershon S
    Science; 1975 Feb; 187(4175):443-5. PubMed ID: 1167428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice.
    Yamaguchi T; Hagiwara Y; Tanaka H; Sugiura T; Waku K; Shoyama Y; Watanabe S; Yamamoto T
    Brain Res; 2001 Aug; 909(1-2):121-6. PubMed ID: 11478928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of cannabinol and cannabidiol on THC-induced responses during abstinence in morphine-dependent rats.
    Hine B; Torrelio M; Gershon S
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):185-8. PubMed ID: 1237925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quasi-morphine withdrawal syndrome: effect of cannabinol, cannabidiol and tetrahydrocannabinol.
    Chesher GB; Jackson DM
    Pharmacol Biochem Behav; 1985 Jul; 23(1):13-5. PubMed ID: 2994117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New in vivo evidence for narcotic agonistic property of leucine-enkephalin.
    Bhargava HN
    J Pharm Sci; 1978 Jan; 67(1):136-7. PubMed ID: 563438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
    Järbe TU; Henriksson BG; Ohlin GC
    Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
    Lichtman AH; Sheikh SM; Loh HH; Martin BR
    J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenylmethanesulfonyl fluoride, a serine protease inhibitor, suppresses naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Nemoto W; Sato T; Nakagawasai O; Yaoita F; Silberring J; Tadano T; Tan-No K
    Neuropeptides; 2013 Jun; 47(3):187-91. PubMed ID: 23290539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
    Aricioglu-Kartal F; Uzbay IT
    Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
    Frederickson RC; Hewes CR; Aiken JW
    J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Precipitation of abstinence-like syndrome in morphine-dependent mice by pargyline.
    Way EL; Iwamoto ET; Khanna S; Ho IK; Shen F; Loh HH
    J Pharmacol Exp Ther; 1976 Nov; 199(2):400-7. PubMed ID: 10429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabidiol attenuates delta 9-tetrahydrocannabinol-like discriminative stimulus effects of cannabinol.
    Hiltunen AJ; Järbe TU
    Eur J Pharmacol; 1986 Jun; 125(2):301-4. PubMed ID: 3017729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenothiazine-type antipsychotics may attenuate naloxone-precipitated withdrawal jumping in morphine-dependent mice.
    Wu SZ; Chen KT; Chen JY; Sung KC; Wang JJ; Liu KS; Chu CC
    Acta Anaesthesiol Taiwan; 2012 Dec; 50(4):167-71. PubMed ID: 23385039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of naloxone-precipitated withdrawal jumps in morphine-dependent mice by stimulation of prostaglandin EP3 receptor.
    Nakagawa T; Minami M; Katsumata S; Ienaga Y; Satoh M
    Br J Pharmacol; 1995 Nov; 116(6):2661-6. PubMed ID: 8590986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid induction and quantitation of morphine dependence in the rat by pellet implantation.
    Bhargava HN
    Psychopharmacology (Berl); 1977 Mar; 52(1):55-62. PubMed ID: 403558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opiate-like action of methionine-enkephalin in inhibiting morphine abstinence syndrome.
    Bhargava HN
    Eur J Pharmacol; 1977 Jan; 41(1):81-4. PubMed ID: 556692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. delta1-tetrahydrocannabinol, cannabidiol and cannabinol effects on the immune response of mice.
    Zimmerman S; Zimmerman AM; Cameron IL; Laurence HL
    Pharmacology; 1977; 15(1):10-23. PubMed ID: 320608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.